Our Partnership
Key Structures
Topics
Results & Data
Impact Stories
Justin’s Fight: Ensuring Every Young Person Can Access HIV Prevention, Testing and Care
Twelve-year-old Francis’ Heroic Fight Against Drug-resistant Tuberculosis
Krayé’s Fight: Protecting His Community and Future Generations Against Malaria
Spotlight on Health Workers Fighting HIV in Sri Lanka
News Releases
Global Fund Applauds Goodbye Malaria’s Contribution to Seventh Replenishment
Luxembourg Increases Pledge by 30% for Global Fund’s Seventh Replenishment
Global Fund and Partners Urge Increased Investment Towards Ending World’s Deadli…
Global Fund Signs Letter of Intent with Pfizer for Oral COVID-19 Treatment
Opinion
President Kenyatta: We Need Vaccines and Investment to Tip the Scales Against Ma…
Ukrainian LGBTI Activist on Breaking Down Barriers to Health Despite Deadly Conf…
The Pivotal Role the Private Sector Can Play in Fight Against TB
Fighting AIDS and COVID-19 Depend on a Firm Foundation
Updates
Opportunity for Evaluation of Pharmaceutical Products - Antiretroviral (HIV/AIDS…
Opportunity for Evaluation of Pharmaceutical Products – Antituberculosis Medicin…
The Global Fund Joins Partners in Committing to Address Large Shortfalls in Oxyg…
A Leap of Pride
Featured
The Five-year Evaluation was a major effort to review the first five years of functioning and performance of the Global Fund as an institution and a partnership, and to identify areas of strength and weakness that would lead to improving day-to-day operations. The Technical Evaluation Reference Group conducted the evaluation after approval by the Global Fund Board.
Additional documents are available for download below.
The Five-Year Evaluation looked at three areas:
Does the Global Fund as an organization (Board, Secretariat, Technical Review Panel, Local Fund Agents) through both its policies and operations, reflect the core principles, including:
In fulfilling these principles, does the Global Fund as an organization perform in an efficient and effective manner?
How effective and efficient is the Global Fund partnership system in supporting HIV, TB and malaria programs at the global and country levels?
What is the Global Fund’s contribution to reducing the burden of the three diseases? What has been the overall reduction on the burden of the three diseases?
Study area 1 was completed in November 2007 and examined the organizational efficiency and effectiveness of the Global Fund, its progress to date and critical areas for improvement. Study area 2, which examined the Global Fund’s partner environment in 16 countries and at the global level, was presented to the Board in November 2008. Study area 3, the health impact evaluation, involved the examination of the collective impact on the burden of AIDS, TB and malaria in 18 countries, and was the most extensive component of the Five-Year Evaluation. It, along with the synthesis report, was presented to the Board in May 2009.
The Global Fund places strong emphasis on the involvement of stakeholders from all sectors and all regions in the design, operation and assessment of its work. Accordingly, to prioritize issues for the Five-Year Evaluation, the Global Fund commissioned an independent assessment of stakeholder opinion on the Global Fund. The 360˚ Stakeholder Assessment was implemented in 2006 to solicit feedback on the organization’s reputation, performance, strengths and weaknesses, and to provide critical insight into diverse stakeholder perspectives.
Its results had a formative role in shaping the focus and methodology of the Five-Year Evaluation. Overall, the results showed that stakeholders generally held high opinions of the Global Fund’s reputation and performance, and supported the approach to the Five-Year Evaluation.
Five-Year Evaluation Reports21
The Global Fund uses cookies for anonymized statistics on website use and content performance to help us improve and adapt the website. To consent to the use of cookies, please click “Accept”. To learn more about your rights and options, please read our Privacy Statement.